<DOC>
	<DOCNO>NCT00255047</DOCNO>
	<brief_summary>The overall aim study corroborate schedule consist 3 dos Pentacel™ 4th dose DAPTACEL® ActHIB® 4 dos Pentacel™ 4 dos Quadracel ActHIB® safe immunogenic standard care schedule base 3 dos licensed-equivalent vaccine DAPTACEL® , Vero cell derive Inactivated Poliovirus vaccine ( IPOL® ) , ActHIB® 4th dose DAPTACEL® ActHIB® .</brief_summary>
	<brief_title>Safety Immune Response Different Pediatric Combination Vaccines .</brief_title>
	<detailed_description />
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<criteria>Aged ≥ 42 day ≤ 89 day day inclusion Born full term pregnancy ( ≥ 36 week ) Informed consent form sign parent ( ) legally authorize representative ( ) 1st study related procedure Vaccination hepatitis B vaccine least 30 day inclusion Able attend schedule visit comply trial procedure ( i.e. , access phone ) Provide blood sample prior Dose 1 Parent legal representative willing take rectal temperature vaccination . Participation another clinical trial 4 week precede ( first ) trial vaccination Planned participation another clinical trial present trial period Personal immediate family history congenital acquire immunodeficiency , immunosuppressive therapy longterm systemic corticosteroid therapy Known suspect systemic hypersensitivity vaccine component history lifethreatening reaction vaccine contain substance trial vaccine ( ) Chronic illness could interfere trial conduct completion Received blood bloodderived product since birth Any vaccination 2 week precede first trial vaccination plan 4 week trial vaccination . Flu vaccine could administer 2 week trial vaccination Previous vaccination acellular pertussis ( DTaP ) whole cell pertussis ( DTwP ) base combination vaccine , Haemophilus influenzae type b ( Hib ) conjugate , poliovirus , pneumococcal conjugate vaccine Coagulation disorder contraindicate intramuscular ( IM ) vaccination Clinically significant finding review system ( determined investigator subinvestigator sufficient exclusion ) Developmental delay neurological disorder Any condition , opinion investigator , would interfere evaluation vaccine pose health risk subject .</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>89 Days</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Pertussis</keyword>
	<keyword>Whooping cough</keyword>
	<keyword>Filamentous Haemagglutinin</keyword>
	<keyword>Fimbriae Types 2 3 ;</keyword>
	<keyword>Pertactin</keyword>
	<keyword>Diphtheria</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Poliovirus Types 1 , 2 , 3 .</keyword>
</DOC>